Mass Balance Study of [14C]HRS9531 in Healthy Male Subjects
Status:
COMPLETED
Trial end date:
2025-06-17
Target enrollment:
Participant gender:
Summary
This study was a single-center, single-dose, open-label study in healthy male subjects to investigate the absorption, metabolism and excretion of HRS9531 after a single subcutaneous injection of \[14C\]HRS9531.